Can AI fake a cell image well enough to fool a lab expert?

NCT ID NCT06542783

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 10, 2026 · Last updated Sep 11, 2026 · Updated 1 time

Summary

Researchers want to know whether computer-generated images of ANA Hep-2 cells look real enough to pass as genuine microscope pictures. They ask 300 experienced lab professionals from multiple medical centers to judge a mix of real and AI-made images and to identify the cell patterns. The study also checks whether seeing AI suggestions changes how accurately those professionals read the patterns.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AI-generated ANA cell images used as a reading aid
What this could lead to
If the images pass as real, labs could use them to train staff and test diagnostic tools without needing as many patient samples. If AI help sharpens pattern reading, autoimmune test results could become more consistent across hospitals.
What could go wrong
This is an observational study with 300 lab professionals, so it measures perception and reading accuracy, not whether patients get better diagnoses. AI-generated images may look convincing yet still miss the biological details that matter, and AI suggestions could bias readers rather than help them.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Jan 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

We are recruiting cytopathologists from clinical laboratories in multiple medical institutions worldwide who specialize in interpreting anti-nuclear antibody (ANA) patterns to participate in a visual Turing test.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Originating from reputable medical institutions * Possessing relevant certification and qualifications * Having over one year of experience in interpreting anti-nuclear antibody (ANA) patterns within a laboratory setting Exclusion Criteria: * Lacking relevant professional certification and qualifications * Without experience in interpreting ANA patterns * Unwilling to accept the rules and informed consent of the visual Turing test

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anti-nuclear antibody are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Clinical Laboratory, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

    Shanghai, Shanghai Municipality, 200092, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.